Company Filing History:
Years Active: 2014-2015
Title: Innovations of Hyung-Jun Ahn
Introduction
Hyung-Jun Ahn is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of innovative delivery systems for small interfering RNA (siRNA). His work has the potential to advance therapeutic strategies for various diseases.
Latest Patents
Hyung-Jun Ahn holds 3 patents that showcase his innovative approaches. One of his latest patents is titled "Recombinant protein for intracellular delivery of siRNA and composition comprising the same." This invention focuses on a recombinant protein that facilitates the efficient intracellular and in vivo delivery of siRNA. The protein allows a siRNA binding protein to be encapsulated within the capsid protein of the Hepatitis B virus, providing stability against external attacks and ensuring effective delivery into the cytosolic space after cell uptake.
Another notable patent is "Fusion protein comprising small heat shock protein, cage protein formed thereby, and novel use thereof." This invention describes a fusion protein that includes a small heat shock protein and a recognition site of a protease. The resulting cage protein exhibits excellent cell permeability and emits a fluorescence signal significantly higher than conventional molecular imaging methods, making it suitable for use as a biosensor or bioactive material carrier.
Career Highlights
Hyung-Jun Ahn is affiliated with the Korea Institute of Science and Technology, where he conducts his research and development activities. His work has garnered attention for its innovative applications in biotechnology and molecular imaging.
Collaborations
He collaborates with notable colleagues, including Ick-Chan Kwon and Kui-Won Choi, to further enhance the impact of his research.
Conclusion
Hyung-Jun Ahn's contributions to the field of biotechnology through his innovative patents demonstrate his commitment to advancing scientific knowledge and therapeutic applications. His work continues to inspire future research in the area of siRNA delivery systems.